Monopar Therapeutics Stock Forecast

Buy or Hold candidate since May 20, 2026 Loss -8.42%

The Monopar Therapeutics Inc. stock price fell by -0.218% on the last day (Friday, 5th Jun 2026) from $59.61 to $59.48. It has now fallen 5 days in a row. During the last trading day the stock fluctuated 5.62% from a day low at $57.70 to a day high of $60.94. The price has fallen in 7 of the last 10 days and is down by -5.11% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -199 thousand shares and in total, 0 shares were bought and sold for approximately $0 .

The stock lies in the middle of a very wide and weak rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 9.43% during the next 3 months and, with a 90% probability hold a price between $57.46 and $73.51 at the end of this 3-month period.

MNPR Signals & Forecast

The Monopar Therapeutics Inc. stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $62.11. On a fall, the stock will find some support from the long-term average at approximately $58.90. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Friday, May 29, 2026, and so far it has fallen -8.55%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell along with the price during the last trading day which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk. The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Monopar Therapeutics Inc. stock

Monopar Therapeutics Inc. finds support from accumulated volume at $58.30 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

In general the stock tends to have very controlled movements and therefore the general risk is considered very low. However, be aware of low or falling volume and make sure to keep an eye on the stock During the last day, the stock moved $3.24 between high and low, or 5.62%. For the last week the stock has had daily average volatility of 5.92%

Our recommended stop-loss: $55.91 (-6.00%) (This stock has very low daily movements and this gives very low risk. There is a sell signal from a pivot top found 5 days ago.)

Trading Expectations (MNPR) For The Upcoming Trading Day Of Monday 8th

For the upcoming trading day on Monday, 8th we expect Monopar Therapeutics Inc. to open at $59.37, and during the day (based on 14 day Average True Range), to move between $57.33 and $61.63, which gives a possible trading interval of +/-$4.29 (+/-7.49%) up or down from last closing price. If Monopar Therapeutics Inc. takes out the full calculated possible swing range there will be an estimated 7.49% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $58.30 (1.98%) than the resistance at $60.99 (2.54%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Monopar Therapeutics Inc. stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Monopar Therapeutics Inc. stock to perform well in the short-term.

Current score: 2.825 Buy Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on June 8, 2026 - $59.37 ( 0.179%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk